Last reviewed · How we verify
ORCA-010
At a glance
| Generic name | ORCA-010 |
|---|---|
| Sponsor | Orca Therapeutics B.V. |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- First in Man Clinical Study to Evaluate Safety and Tolerability of an Oncolytic Adenovirus in Prostate Cancer Patients. (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- ORCA-010 CI brief — competitive landscape report
- ORCA-010 updates RSS · CI watch RSS
- Orca Therapeutics B.V. portfolio CI